Unknown

Dataset Information

0

Prognostic and therapeutic relevance of cathepsin B in pediatric acute myeloid leukemia.


ABSTRACT: AML, the second most common childhood leukemia is also one of the deadliest cancers. High mortality rate in AML is due to high incidence of relapse after complete remission with chemotherapy and inadequate prognostic assessment of patients. Moreover, there is dearth of therapeutic targets for treatment of this malignancy. Previous pilot study (n = 24) by our group revealed strong association between cathepsin B (CTSB) overexpression in peripheral blood mononuclear cells (PBMCs) and poor survival outcome in pediatric AML patients. To further explore the clinical utility and role of this protease in pediatric AML, we measured its enzymatic activity and mRNA expression in PBMCs as well as bone marrow mononuclear cells (BMMCs) of patients (n = 101) and PBMCs of healthy controls. Our results revealed elevated CTSB activity (P < 0.01) and overexpression of its mRNA (P < 0.01) in AML patients. Interestingly CTSB in BMMCs of patients emerged as an independent prognostic marker when compared with other known risk factors. Moreover, chemical inhibition of CTSB activity compromised survival, and induced apoptosis in an AML cell line THP-1. We further demonstrate the inhibition of CTSB activity by chemotherapeutic agent doxorubicin in these cells. Docking and simulation studies suggested the binding of doxorubicin to CTSB with higher affinity than its known specific inhibitor CA-074 Me, thereby indicating that cell death induced by this drug may at least partly be mediated by CTSB inhibition. CTSB, therefore, may serve as a prognostic marker and an attractive chemotherapeutic target in pediatric AML.

SUBMITTER: Pandey G 

PROVIDER: S-EPMC6943344 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Prognostic and therapeutic relevance of cathepsin B in pediatric acute myeloid leukemia.

Pandey Garima G   Bakhshi Sameer S   Kumar Manoj M   Thakur Bhaskar B   Jain Prerna P   Kaur Punit P   Chauhan Shyam S SS  

American journal of cancer research 20191201 12


AML, the second most common childhood leukemia is also one of the deadliest cancers. High mortality rate in AML is due to high incidence of relapse after complete remission with chemotherapy and inadequate prognostic assessment of patients. Moreover, there is dearth of therapeutic targets for treatment of this malignancy. Previous pilot study (n = 24) by our group revealed strong association between cathepsin B (CTSB) overexpression in peripheral blood mononuclear cells (PBMCs) and poor survival  ...[more]

Similar Datasets

| S-EPMC3957536 | biostudies-literature
| S-EPMC3545649 | biostudies-literature
| S-EPMC5070622 | biostudies-literature
| S-EPMC7261725 | biostudies-literature
| S-EPMC9768963 | biostudies-literature
| S-EPMC8300536 | biostudies-literature
| S-EPMC4219441 | biostudies-other
| S-EPMC9375597 | biostudies-literature
| S-EPMC8417965 | biostudies-literature
| S-EPMC6407682 | biostudies-literature